Plasmodium falciparum antigens as target molecules for a protective immunization against malaria: an up-to-date review.
D000276:Adjuvants, Immunologic; D000595:Amino Acid Sequence; D000818:Animals; D000852:Anopheles / Q000276:immunology / Q000469:parasitology; D000911:Antibodies, Monoclonal / Q000276:immunology; D000953:Antigens, Protozoan / Q000235:genetics / Q000276:immunology*; D000954:Antigens, Surface / Q000235:genetics / Q000276:immunology*; D003001:Cloning, Molecular; D004910:Erythrocyte Membrane / Q000276:immunology; D006801:Humans; D007110:Immunity, Active; D008288:Malaria / Q000276:immunology* / Q000517:prevention & control; D010455:Peptides / Q000276:immunology; D010963:Plasmodium falciparum / Q000254:growth & development / Q000276:immunology*; D015800:Protozoan Proteins; D014611:Vaccination; D014612:Vaccines
D000276:Adjuvants, Immunologic; D000911:Antibodies, Monoclonal; D000953:Antigens, Protozoan; D000954:Antigens, Surface; D010455:Peptides; D015800:Protozoan Proteins; D014612:Vaccines; C041595:circumsporozoite protein, Protozoan; C042968:knob protein, Plasmodium falciparum